October 2017

BTS Hero Retheme

We explore the complex processes of biology and apply what we learn to the development and rational use of therapeutics to improve health.

Novel diabetes treatment developed in Desai Lab to power SF-area startup

Thu Oct 19, 2017

A UC San Francisco-created, insulin-generating implant that utilizes nanotechnology is closer to becoming a real treatment for diabetes, after being acquired by a San Francisco-based startup.

The biotechnology company Encellin acquired exclusive worldwide rights to the technology, originally developed in the laboratory of Tejal Desai, PhD, chair of the Department of Bioengineering and Therapeutic Sciences, a joint department of the UCSF Schools of Pharmacy and Medicine.

Celebrating Hubert Sylvester

Mon Oct 16, 2017

The Department of Bioengineering and Therapeutic Sciences (BTS) is celebrating Hubert Sylvester on the occasion of his 35th employment anniversary at UCSF.

Before joining the staff at UCSF, Sylvester was attending college. Over the course of his UCSF career, he has served as a clerk, an assistant store keeper, a member of the purchasing staff, and now as a purchasing analyst.

Wired magazine visits The Kidney Project

Fri Oct 6, 2017

Kidney failure is a debilitating and ultimately deadly illness, and a health policy crisis. With 468,000 people on dialysis in the U.S., costing the government $31 billion dollars a year, very little money is spent on researching alternatives to current treatments.